For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $7.83 in the prior trading day, Avadel Pharmaceuticals plc (NASDAQ: AVDL) closed at $7.51, down -4.09%. In other words, the price has decreased by -$4.09 from its previous closing price. On the day, 0.88 million shares were traded. AVDL stock price reached its highest trading level at $7.7508 during the session, while it also had its lowest trading level at $7.425.
Ratios:
Our goal is to gain a better understanding of AVDL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.33 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 0.50 whereas as Long-Term Debt/Eq ratio is at 0.49.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Deutsche Bank on February 11, 2025, initiated with a Buy rating and assigned the stock a target price of $12.
On June 12, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $27.
Oppenheimer reiterated its Outperform rating for the stock on March 05, 2024, while the target price for the stock was revised from $27 to $29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 21 ’25 when Palczuk Linda bought 5,000 shares for $7.93 per share. The transaction valued at 39,640 led to the insider holds 67,900 shares of the business.
Thornton Peter J. bought 10,000 shares of AVDL for $80,450 on Jan 13 ’25. The Director now owns 104,055 shares after completing the transaction at $8.04 per share. On Jan 13 ’25, another insider, Ende Eric J, who serves as the Director of the company, bought 30,000 shares for $7.84 each. As a result, the insider paid 235,218 and bolstered with 208,900 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVDL now has a Market Capitalization of 725686848 and an Enterprise Value of 690753088. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.29 while its Price-to-Book (P/B) ratio in mrq is 9.82. Its current Enterprise Value per Revenue stands at 4.084 whereas that against EBITDA is -17.391.
Stock Price History:
The Beta on a monthly basis for AVDL is 1.52, which has changed by -0.53898096 over the last 52 weeks, in comparison to a change of 0.08089435 over the same period for the S&P500. Over the past 52 weeks, AVDL has reached a high of $19.09, while it has fallen to a 52-week low of $7.39. The 50-Day Moving Average of the stock is -7.96%, while the 200-Day Moving Average is calculated to be -38.10%.
Shares Statistics:
The stock has traded on average 1.39M shares per day over the past 3-months and 735410 shares per day over the last 10 days, according to various share statistics. A total of 96.52M shares are outstanding, with a floating share count of 88.27M. Insiders hold about 8.65% of the company’s shares, while institutions hold 80.03% stake in the company. Shares short for AVDL as of 1741910400 were 9424834 with a Short Ratio of 6.77, compared to 1739491200 on 10354846. Therefore, it implies a Short% of Shares Outstanding of 9424834 and a Short% of Float of 11.4700004.
